Armata Pharmaceuticals, Inc. (ARMP)
5.77
+0.10
(+1.76%)
USD |
NYAM |
Dec 11, 16:00
5.76
-0.01
(-0.17%)
Pre-Market: 09:03
Armata Pharmaceuticals Research and Development Expense (TTM): 26.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agenus, Inc. | 105.60M |
| Integer Holdings Corp. | 50.00M |
| Liquidia Corp. | 37.78M |
| AIM ImmunoTech, Inc. | 3.826M |
| Protalix Biotherapeutics, Inc. | 18.06M |